First-ever research network tackles diabetic foot complications
Foot ulcers are the leading cause of lower limb amputations in the United States.
EGT posts 600th Guideline Brief and Scorecard!
EGT has reached yet another milestone and has published its 600th Guideline Brief and Scorecard. This represents guidelines from 77 developer organizations and covers more than 52 clinical topics.
Even a Few Days of Steroids May Be Risky
Individually tailored falls prevention plan found no better than usual care for reducing serious injury
Large PCORI-, NIH-funded trial examined multipronged intervention in real-world settings.
Cardiovascular Health and Prevention Remain Priorities During a Pandemic
Million Hearts® understands that hospitals and health systems are challenged, working hard, and adjusting to meet the needs of their patients, employees, and communities during the pandemic. Focusing on cardiovascular health has never been more important. The Million Hearts® Hospitals & Health Systems Recognition Program recognizes institutions working systematically to improve the cardiovascular health of their communities through focus on Million Hearts® priority areas:
- Keeping People Healthy
- Optimizing Care
- Improving Outcomes for Priority Populations
- Innovating for Health
The application for recognition remains open to multihospital health systems, hospitals with and without ambulatory care, medical practices unaffiliated with hospitals, community health centers, and any clinical entity whose leaders consider it eligible. Even if an institution chooses not to apply, the application form itself offers a plethora of proven strategies for improving the cardiovascular health of patients and communities.
Apply now; our next review deadline in July 30, 2020. Achieve a Million Hearts® Hospitals & Health Systems designation to showcase your institution’s commitment to both clinical quality and overall cardiovascular health.
My heart is with you in support.
Laurence Sperling, MD, FACC, FACP, FAHA, FASPC
Executive Director, Million Hearts®
Final Recommendation Statement: Screening for Unhealthy Drug Use
The U.S. Preventive Services Task Force released today a final recommendation statement on screening for unhealthy drug use. That Task Force found that clinicians should ask adults about their drug use and connect people who have a problem to care. More research is needed to make a recommendation for teens. The final recommendation statement can also be found in the June 9, 2020 online issue of JAMA.
Study identifies potential approach to treat severe respiratory distress in patients with COVID-19
These findings should not be considered clinical advice but are being shared to assist the public health response to COVID-19
State of Aging and Health in America: Data Brief Series are topic-specific documents focusing on public health issues related to older adults. These briefs provide public health professionals with the most recent data available on health and aging related conditions, including the importance of brain health, the management of chronic conditions, and caregiving burdens, to help identify needs and mitigate the future effects of a growing older population.
NIH releases strategic plan to accelerate nutrition research over next 10 years
What if each of us had individualized dietary recommendations that helped us decide what, when, why, and how to eat to optimize our health and quality of life? This precision nutrition approach — developing targeted and effective diet interventions in a diverse population — is among the ambitious goals set out by the 2020-2030 Strategic Plan for National Institutes of Health Nutrition Research.
COVID-19 Guidance for Older Adults
Older adults, 65 years and older, are at higher risk for severe illness. COVID-19 is a new disease and we are learning more about it every day. Information is available in multiple languages.
Are You Aware? Quick Facts About Kidney Disease
In the United States, nearly half (45%) of adults have high blood pressure, or hypertension,1 a principal or contributing cause of death for more than 472,000 people in 2017.2 Hypertension and chronic kidney disease (CKD) are closely linked. Hypertension is not only among the most important risk factors for CKD but is almost always present in people with CKD, occuring in 85% to 95% of those with advanced CKD (stages 3–5).3
Albuminuria, or protein in the urine, is associated with duration and severity of hypertension and is a risk factor for CKD and CKD progression, cardiovascular events such as heart attacks and stroke, and early death.4 Despite guidelines to screen for albuminuria in all patients with hypertension,5,6 urine albumin testing is not frequently done in clinical practice. In the Veterans Health Administration system, although the percentage of patients with urine albumin results was higher with increasing age, less than one-third of patients with hypertension were tested for albuminuria in 2018 (figure).
Laboratory tests for albuminuria are reliable, simple, and relatively inexpensive. Testing is an important step to identifying CKD and evaluating risk for cardiovascular disease and kidney disease progression. This is especially needed among patients with hypertension.
- Centers for Disease Control and Prevention (CDC). Hypertension Cascade: Hypertension Prevalence, Treatment and Control Estimates Among US Adults Aged 18 Years and Older Applying the Criteria From the American College of Cardiology and American Heart Association’s 2017 Hypertension Guideline—NHANES 2013–2016. Atlanta, GA: US Department of Health and Human Services; 2019.
- Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying Cause of Death, 1999–2017. CDC WONDER Online Database. Atlanta, GA: Centers for Disease Control and Prevention; 2018. Accessed January 7, 2019.
- Rao MV, Qiu Y, Wang C, Bakris G. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999–2004. Am J Kidney Dis. 2008;51(4 suppl 2):S30–S37.
- Matsushita K, Ballew SH, Astor BC, et al. Cohort profile: the Chronic Kidney Disease Prognosis Consortium. Int J Epidemiol. 2013;42(6):1660–1668.
- Krammer HJ, Townsend RR, Griffin K, et al. KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline. Am J Kidney Dis. 2019;73(4):437–458.
- Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105–1187.
Curriculum on Alzheimer’s Disease—-NEW COVID-19 American Sign Language Videos
As Alzheimer’s disease gains more national attention as a public health crisis, the Centers for Disease Control and Prevention, the Alzheimer’s Association, and Emory University’s Rollins School of Public Health have an updated, flexible resource to help prepare the future public health workforce.
A Public Health Approach to Alzheimer’s and Other Dementias is a free curricular resource created for use by university faculty. The curriculum introduces students of public health and related disciplines to information about Alzheimer’s and other dementias, as well as to public health approaches to address Alzheimer’s as a multilayered, growing public health challenge.
NEW — Module 2
- Modules are peer-reviewed and ready to use.
- Modules can be used together or individually.
- Faculty can easily adapt and incorporate the modules into existing course content.
- Curriculum content is linked to public health competencies.
Each module includes a faculty guide and a PowerPoint presentation with talking points, as well as selected case studies, video resources, sample test questions, and engaging learning activities for the classroom.
COVID-19: Guidance for Older Adults
NEW: Videos in American Sign Language
Older adults are at higher risk of getting sick and having significant health complications from the coronavirus disease 2019 (COVID-19).
Expert U.S. panel develops NIH treatment guidelines for COVID-19
“Living document” expected to be updated often as new clinical data accrue.
EHC Program Update: Treatments for Chronic Pain Final Reports Now Available
Systematic Reviews Now Available
Opioid Treatments for Chronic Pain
(Systematic Review, released on April 16, 2020)
The review assesses the effectiveness and harms of opioid therapy for chronic noncancer pain, alternative opioid dosing strategies, and risk mitigation strategies.
Nonopioid Pharmacologic Treatments for Chronic Pain
(Systematic Review, released on April 16, 2020)
The review evaluates the benefits and harms of nonopioid drugs in randomized controlled trials of patients with specific types of chronic pain, considering the effects on pain, function, quality of life, and adverse events.
Noninvasive Nonpharmacological Treatment for Chronic Pain
(Systematic Review, released on April 16, 2020)
The review assesses noninvasive nonpharmacological treatments for common chronic pain conditions.
Large-scale analysis links glucose metabolism proteins in the brain to Alzheimer’s disease biology
NIH-funded research reveals protein network changes that may be druggable targets, biomarkers.
Alzheimer’s trial screening data links high amyloid levels with early stage disease
First paper from NIH-funded “A4” study supports amyloid as target for prevention.
NIDA Director outlines potential risks to people who smoke and use drugs during COVID-19 pandemic
The piece raises several important concerns regarding COVID-19 for specific vulnerable populations.
The National Library of Medicine expands access to coronavirus literature through PubMed Central
The National Library of Medicine (NLM), part of the National Institutes of Health, is working on multiple fronts to aid in the COVID-19 response through new initiatives with the global publishing community and artificial intelligence researchers. NLM is expanding access to scientific papers on coronavirus for researchers, care providers, and the public, and for text-mining research. This work makes use of NLM’s PubMed Central® (PMC), a digital archive of peer-reviewed biomedical and life sciences literature. PMC currently provides access to nearly 6 million full-text journal articles.
CDC High Obesity Program
CDC’s Division of Nutrition, Physical Activity, and Obesity launched a program called Programs to Reduce Obesity in High Obesity Areas, also referred to as HOP, and this collection highlights the program’s approach and describes both overarching and program-specific evaluation findings. Seven of the articles highlight the work of land-grant universities, and one describes HOP’s implementation approach, evaluation framework, and key findings.
New coronavirus stable for hours on surfaces
SARS-CoV-2 stability similar to original SARS virus.
Blood test method may predict Alzheimer’s protein deposits in brain
NIH-funded study reports advance in blood-based detection of ptau181, a biomarker of Alzheimer’s disease.
Study finds irregular sleep patterns double the risk of cardiovascular disease in older adults
Variability in sleep duration and timing may represent new and independent heart disease risk factor.
NIH clinical trial of remdesivir to treat COVID-19 begins
Study enrolling hospitalized adults with COVID-19 in Nebraska.
Opioids and Opioid Use Disorder TEP Final Report
This report considers issues related to acute and chronic pain management and substance use disorders (SUD). The guidance provided aims to achieve the application of the proper healthcare quality metrics across the U.S. healthcare system. Using the best metrics, in turn, seeks both to continue to reduce opioid deaths verifiably, to encourage the implementation of best practices of pain management, to decrease the incidence of other SUDs, and to decrease illegal drug use by those unable to obtain prescription pain medication.
Neural Signature Identifies People Likely to Respond to Antidepressant Medication
Researchers have discovered a neural signature that predicts whether individuals with depression are likely to benefit from sertraline, a commonly prescribed antidepressant medication. The findings, published in Nature Biotechnology, suggest that new machine learning techniques can identify complex patterns in a person’s brain activity that correlate with meaningful clinical outcomes.
AHRQ Views Blog: New Guide to Help Primary Care Practices Manage Opioid Patients
A new guide to help primary care practices manage patients taking opioids for chronic pain is highlighted in a new post by AHRQ Director Gopal Khanna, M.B.A. The new Self-Service How-To Guide helps practices implement the AHRQ-funded Six Building Blocks, a structured, systems-based approach to treating patients who use long-term opioid therapy. Clinicians and staff, quality improvement personnel, practice coaches, and clinic administrators can use the new guide to implement the Six Building Blocks in a three-stage,15-month timeline. Developing tools and resources to reduce opioid overdoses and the prevalence of opioid use disorder is a priority for the U.S. Department of Health and Human Services and AHRQ.
Opioid-Benzo Co-Prescribing Continues, Despite Risks One-third of office visits with benzodiazepine prescriptions involve overlapping opioids
The Public Health Road Map to Respond to the Growing Dementia Crisis
Patients with newly diagnosed musculoskeletal pain are prescribed opioids more often than recommended
NIH study shows treatment recommendations impacted by patient and physician factors.